Artificial Organs Market Size to grow by USD 14854.5 million between 2024-2028
According to a research report “ Artificial Organs Market” by Usage (Implantable, Extracorporeal) Product (Artificial heart, Artificial kidney, Cochlear implants, Artificial pancreas) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 14854.5 million, at a CAGR of almost 9.49% during the forecast period. The rising prevalence of chronic conditions, including diabetes, kidney diseases, hearing disorders, and cardiovascular diseases (CVDs), such as strokes and cardiac diseases, is driving the demand for artificial organs. Factors contributing to this trend include an aging population, physical inactivity, and unhealthy diets leading to conditions like hypertension, obesity, abnormal cholesterol, and diabetes. According to the CDC's 2021 report, approximately 795,000 Americans experience a stroke annually. The increasing incidence and prevalence of CVDs, including strokes, myocardial infarction, and coronary artery diseases, necessitate the development and implementation of advanced artificial organ solutions.
Browse market data tables, figures, and in-depth TOC on “Artificial Organs Market” by Usage (Implantable, Extracorporeal) Product (Artificial heart, Artificial kidney, Cochlear implants, Artificial pancreas) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By Usage, the Implantable segment is projected to dominate the market size in 2024
The Artificial Organs Market represents a significant and growing business sector, driven by advancements in medical technology and the increasing demand for organ transplants. This market encompasses the production and distribution of various types of artificial organs, including hearts, kidneys, livers, and lungs, to save and improve the lives of patients with organ failure. Companies in this sector invest heavily in research and development to create innovative solutions that meet the evolving needs of healthcare providers and patients. The market is expected to experience robust growth due to the rising prevalence of chronic diseases, increasing geriatric population, and improving reimbursement policies.
By Product, Artificial heart segment is expected to hold the largest market size for the year 2024
The Artificial Organs Market represents a significant and growing business sector, driven by advancements in medical technology and the increasing prevalence of organ failures. This market encompasses the production and distribution of various types of artificial organs, including hearts, kidneys, livers, and lungs, to meet the demands of patients requiring organ transplants. Companies in this sector focus on research and development, manufacturing, and marketing to provide life-saving solutions for those in need.
North America is forecasted to hold the largest market size by region in 2024
The Artificial Organs Market represents a significant and growing business sector, driven by advances in medical technology and the increasing global burden of chronic diseases. This market encompasses the production and distribution of various types of artificial organs, including hearts, lungs, kidneys, and livers, to meet the critical needs of patients requiring organ transplants. Market growth is fueled by rising demand, technological innovations, and government initiatives to expand access to life-saving treatments.
The Artificial Organs Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
Artificial organs have revolutionized the medical field, providing solutions for individuals suffering from nutrient and oxygen deficiencies due to organ failures or transplant surgeries. These organs, made from materials like steel, plastics, and silicon, offer temporary and permanent solutions for patients with renal replacement needs, such as those suffering from end-stage kidney disease or kidney failure. Vascularization is a critical aspect of artificial organs, ensuring the proper flow of nutrients and oxygen to the body. Advanced technologies like artificial intelligence are being used to improve the vascularization process and reduce organ rejection. Transplant surgeries for organs like the kidney, liver, and pancreas are common procedures that utilize both donated and artificial organs. However, organ donors remain scarce, leading to a growing demand for temporary and permanent artificial organs. Apheresis therapy is another application of artificial organs, used to treat respiratory diseases and heart diseases. Artificial organs like the artificial liver, artificial pancreas, and artificial kidney have become essential tools in medical care. Dialysis, a common treatment for kidney failure, relies on artificial kidneys to filter waste from the blood. The future of artificial organs holds great promise, with ongoing research and development in this field. Organ failures can occur due to various reasons, including road accidents and organ rejection. Live donor programs offer a solution for some patients, but artificial organs provide a viable alternative for those who do not have access to donors or who require long-term support. In conclusion, artificial organs play a crucial role in providing nutrients and oxygen to the body when natural organs fail. With advancements in technology and materials, these organs offer hope for individuals suffering from various organ failures and diseases.
Market Research Overview
Artificial organs have emerged as a promising solution for individuals suffering from various chronic diseases, including Type 1 diabetes, cardiovascular diseases, respiratory diseases, and kidney failure. Cochlear implants are a successful example of artificial organs that have revolutionized hearing restoration. Continuous glucose monitors help manage diabetes, but artificial pancreas systems offer more advanced solutions. Biotechnology advances have led to the development of artificial organs for oxygenation and nutrient transport, such as lung substitutes and kidney substitutes. These temporary or permanent solutions involve organ retrieval and processing technologies, including decellularization, plasma separation, and biomaterials. Organ transplantation remains a critical solution for end-stage organ failure. However, challenges like organ rejection, procedure costs, and side effects persist. Innovations like 3D bioprinting, artificial intelligence, and organ donor programs are addressing these issues. Artificial organs made of steel, plastics, and silicon include the artificial liver, pancreas, kidney, lungs, heart, and even limbs for amputees. These organs address conditions like cancer, hypertension, renal failure, and dialysis. Despite advancements, challenges remain, including the high costs, potential skin irritation, and transplant side effects. Nevertheless, ongoing research and advancements in technologies like CPB, hemodialysis, apheresis therapy, and transplant surgeries continue to improve the quality of life for millions.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
